Mayne Pharma Group Limited (ASX: MYX) – New acquisition and agreement

The generic Efudex’ (fluorouracil cream 5%) acquisition from Spear Pharmaceuticals, Inc., comprising of US$16.0 million in cash and US$4.0 million in Mayne Pharma equity for the total of US$20.0 million, plus contingent payments of up to US$10.0 million, has been … Continue reading Mayne Pharma Group Limited (ASX: MYX) – New acquisition and agreement

Western Areas Limited (ASX: WSA) – Mine production at its peak!

Western Areas Limited (ASX: WSA) has recently reported a stronger June quarter of cashflow generation for the year with cash at bank increasing by A$15.9m to A$151.6m, after capital expenditure, feasibility study and exploration costs of A$12.5m. The Company’s balance sheet … Continue reading Western Areas Limited (ASX: WSA) – Mine production at its peak!

Navitas Limited – Footprint Expansion into Netherlands via Partnership with University of Twente

Navitas Limited (ASX: NVT) inked an agreement with University of Twente to take over its pathway program for international students. The agreement takes after NVT effectively competing in the university’s selection procedure for the provision of these services. As per … Continue reading Navitas Limited – Footprint Expansion into Netherlands via Partnership with University of Twente

Lynas Corporation Limited (ASX:LYC) – Higher production in June quarter

Lynas Corporation Limited (ASX: LYC) demonstrated strong operational performance in the June quarter with cash flows from operating activities of A$20.7 million and record production volumes achieved at the same time as major Lynas NEXT upgrades were completed. Lynas made … Continue reading Lynas Corporation Limited (ASX:LYC) – Higher production in June quarter